Community Schedule

Enter at least 4 characters

1 results showing for: 'pneumococcal (pcv13) conjugate vaccine'

Pneumococcal (PCV13) conjugate vaccine    Medsafe Data Sheets   New Zealand Formulary.   Hospital Medicines List.   PDF Schedule - Refer from page 303.
  • Inj 30.8 mcg of pneumococcal polysaccharide serotypes 1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F and 23F in 0.5ml syringe
    • Brand Fully subsidised brand. Prevenar 13
    • Pharmacode2383047
    • Subsidy $0.00
    • Measure / Qty per 1
    • Brand Fully subsidised brand. Prevenar 13
    • Pharmacode2451085
    • Subsidy $0.00
    • Measure / Qty per 10

Any of the following:

  1. Two doses are funded for high risk children (over the age of 12 months and under 18 years) who have previously received two doses of the primary course of PCV10; or

  2. Up to an additional four doses (as appropriate) are funded for high risk children aged under 5 years for (re-)immunisation of patients with any of the following:

    1. on immunosuppressive therapy or radiation therapy, vaccinate when there is expected to be a sufficient immune response; or

    2. with primary immune deficiencies; or

    3. with HIV infection; or

    4. with renal failure, or nephrotic syndrome; or

    5. who are immune-suppressed following organ transplantation (including haematopoietic stem cell transplant); or

    6. with cochlear implants or intracranial shunts; or

    7. with cerebrospinal fluid leaks; or

    8. receiving corticosteroid therapy for more than two weeks, and who are on an equivalent daily dosage of prednisone of 2 mg/kg per day or greater, or children who weigh more than 10 kg on a total daily dosage of 20 mg or greater; or

    9. with chronic pulmonary disease (including asthma treated with high-dose corticosteroid therapy); or

    10. pre term infants, born before 28 weeks gestation; or

    11. with cardiac disease, with cyanosis or failure; or

    12. with diabetes; or

    13. with Down syndrome; or

    14. who are pre-or post-splenectomy, or with functional asplenia; or

  3. Up to an additional four doses (as appropriate) are funded for (re-)immunisation of patients 5 years and over with HIV, for patients pre or post haematopoietic stem cell transplantation, or chemotherapy; pre- or post splenectomy; functional asplenia, pre- or post- solid organ transplant, renal dialysis, complement deficiency (acquired or inherited), cochlear implants, intracranial shunts, cerebrospinal fluid leaks or primary immunodeficiency; or

  4. For use in testing for primary immunodeficiency diseases, on the recommendation of an internal medicine physician or paediatrician.

Note: please refer to the Immunisation Handbook for the appropriate schedule for catch up programmes

  • Rectangle page icon symoblising a PDF. PDF
  • A tick icon. Fully subsidised
  • An oval with the number 29 in it. Unapproved medicine under Section 29
  • An asterisk symbol. 3 or 6 months should be dispensed at once
  • Two duplicate pages icon. Click to copy
  • A triangle symbol. Three months supply may be dispensed at one time if endorsed "certified exemption" by the prescriber or pharmacist.
  • OP Original pack
  • Sole Subsidised Supply